BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.10bn
- IN₹1.11bn
- IN₹300.35m
Annual cashflow statement for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.98 | 14.6 | 19.2 | 10.1 | 7.93 |
| Depreciation | |||||
| Non-Cash Items | 1.6 | 1.49 | 0.727 | 0.507 | -0.541 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.32 | -11.3 | -12.9 | -17.1 | -12.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12.6 | 8.94 | 11.1 | -2.2 | -1.12 |
| Capital Expenditures | -14.1 | -2.07 | -5.67 | -0.699 | -0.106 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0 | 4.71 | 0 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -14.1 | -2.07 | -0.961 | -0.699 | -0.106 |
| Financing Cash Flow Items | -1.6 | -1.22 | -0.681 | -0.406 | -0.425 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.816 | -5.68 | -8.3 | -0.058 | 0.151 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.38 | 1.2 | 1.84 | -2.96 | -1.07 |